ELUTIA INC

For the period ended Mar 31, 2024. Filed May 13, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 13, 2024

ELUT$0.84-0.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

(In Thousands, Except for Share and Per Share Data)


· · March 31, · · December 31, ·
· 2024 · 2023
Assets
Current assets:
Cash	$12,551	$19,276
Accounts receivable, net	4,406	3,263
Inventory	3,052	3,853
Receivables of litigation costs	2,031	2,696
Prepaid expenses and other current assets	1,946	2,165
Total current assets	23,986	31,253

Property and equipment, net	171	172
Intangible assets, net	10,822	11,671
Operating lease right-of-use assets and other	383	332
Total assets	$35,362	$43,428

Liabilities and Stockholders’ Deficit

Current liabilities:
Accounts payable	$4,156	$2,285
Accrued expenses	9,022	9,485
Payables to tissue suppliers	907	906
Current portion of long-term debt	2,274	3,321
Current portion of revenue interest obligation	5,900	11,741
Contingent liability for FiberCel litigation	15,591	15,024
Current operating lease liabilities	217	275
Total current liabilities	38,067	43,037

Long-term debt	19,738	20,356
Long-term revenue interest obligation	7,659	5,360
Warrant liability	19,503	12,760
Other long-term liabilities	694	515
Total liabilities	85,661	82,028

Commitments and contingencies (Note 10)

Stockholders’ equity (deficit):
Class A Common stock, $0.001 par value per share, 200,000,000 shares authorized as of March 31, 2024 and December 31, 2023, and 20,036,508 and 18,884,196 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	20	19
Class B Common stock, $0.001 par value per share, 20,000,000 shares authorized as of March 31, 2024 and December 31, 2023 and 4,313,406 issued and outstanding as of March 31, 2024 and December 31, 2023	4	4
Additional paid-in capital	143,315	137,021
Accumulated deficit	(193,638)	(175,644)
Total stockholders’ deficit	(50,299)	(38,600)
Total liabilities and stockholders' deficit	$35,362	$43,428

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.